33rd Hemophilia Symposium: Hamburg 2002

Front Matter....Pages I-XXXII
Front Matter....Pages 1-1
HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2001/2002 Survey)....Pages 3-12
Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association — Annual Survey 2002....Pages 13-18
»New Viruses« and the Safety of Factor Concentrates and Stable Blood Products: TT Virus and West Nile Virus as Current Examples....Pages 19-20
Front Matter....Pages 21-21
A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII....Pages 23-26
Characterisation of Factor VIII-Inhibitory Antibodies Using Phage Display....Pages 27-34
Rituximab — A new Treatment of Acquired Hemophilia A?....Pages 35-37
Thrombin Generation and Thrombogram: Assays for Monitoring Factor VIII Bypassing Therapies....Pages 38-47
Front Matter....Pages 48-48
Rehabilitation — A Topic for Hemophiliacs?....Pages 51-56
Functional Analysis as a Basis for Optimizing Physiotherapy in Hemophilic Children....Pages 57-65
Sport and Physical Fitness Recommendations for Young Hemophiliacs....Pages 66-73
Pain Versus Clinical and Radiological Assessment in Hemophilic Arthropathies....Pages 74-84
Front Matter....Pages 85-85
Endogenous Thrombin Potential in Platelet-Rich Plasma — New Insights Regarding the Different Action of FVIII and FIX....Pages 87-93
Front Matter....Pages 95-95
Interactive and Case-Based Training of Diagnostic Skills and Therapeutical Management of Coagulation Disorders with CAMPUS, a Computer-Based Program....Pages 97-100
Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children....Pages 101-105
Increased von-Willebrand-Factor-Binding to Platelets in Neonatal Plasma....Pages 106-109
Neonatal Protein C Deficiency after massive thromboembolic Event of the right upper Limb — Treatment with Protein C Concentrate....Pages 110-114
Front Matter....Pages 115-115
IMMUNATE S/D — A new Factor VIII — von-Willebrand Factor Complex Concentrate....Pages 117-134
Favorable Response to Protein C in Venoocclusive Disease after Allogeneous Stem Cell Transplantation....Pages 135-142
Phase III Clinical Evaluation of rAHF-PFM Prepared Using a Plasma/Albumin Free Method....Pages 143-149
Anti-Prionin IgG, Possible new Serum Markers for Contact and Infection with Transmissible Spongiform Encephalopathies: Preliminary Results from Screening 100 Blood Donors....Pages 150-152
Front Matter....Pages 115-115
Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells....Pages 153-158
Von-Willebrand Factor Cleaving Protease (ADAMTS-13) Activity in Various Thrombotic, Hemolytic and Autoimmune Disorders....Pages 159-164
Front Matter....Pages 165-165
Treatment with Interferon Alpha-2a in Patients with Hepatitis C and Hemophilia....Pages 167-172
Practical Experiences with Therapies for Chronic Hepatitis C in Hemophilia Patients....Pages 173-175
Deep Venous Thrombosis of the Lower Extremity in a 16-Year-Old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation....Pages 176-178
Clinical Manifestations of Patients with Highly Elevated Anticardiolipin Antibodies....Pages 179-184
Progression of an Extensive Deep Vein Thrombosis under High Dose Therapy with low Molecular Weight Heparin of a 13-Year-Old Girl Suffering from Colitis Ulcerosa....Pages 185-186
Hyperfibrinolysis in Hemophagocytic Lymphohistiocytosis....Pages 187-191
Prolonged Lysis-Therapy of an Arteria Iliaca Externa Thrombosis in a very Low Birth Weight Infant with a Variant in the Factor-XIII-Gene....Pages 192-195
Modified Immunsuppression in a Case of Acquired Hemophilia — Case Report....Pages 196-198
Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A....Pages 199-200
Administration of Protein C Concentrate (Ceprotin, Baxter) in Purpura Fulminans as the First Clinical Manifestation of Galactosemia....Pages 201-204
Case Report: Successful Treatment of a Spontaneous Acquired Inhibitor Against Factor VIII in a 73-Year-old Patient....Pages 205-207
Medical Need and Quality of Life in Patients with Hemophilia A....Pages 211-215
Quality of Life Autoevaluation of Hemophilia Patients in Romania....Pages 216-221
Valproate-Induced Type I von-Willebrand Disease — a Common Occurrence?....Pages 222-227
Bleeding Symptoms in Carriers of Hemophilia A — Association to the Factor VIII Gene Mutation?....Pages 228-231
Recombinant Human Interferon α-2b Therapy, for Refractory Immune Thrombocytopenic Purpura in Children....Pages 232-236
Review on Bleeding Episodes in Hemophiliacs Receiving no Primary Prophylactic Replacement Therapy....Pages 237-249
Endogenous Thrombin Potential and Thrombin Activatable Fibrinolysis Inhibitor in Patients with Hemophilia and von-Willebrand disease....Pages 250-254
Front Matter....Pages 165-165
Different Thrombotic Risk Factors — Contribution to the Endogenous Thrombin Potential....Pages 257-261
Coagulation Parameters in Pregnancy: Low-Molecular-Weight Heparin Prophylaxis in Women with Thrombophilic Risk Factors....Pages 262-265
Malignancy is not Associated with Decreased ADAMTS-13 Activity in Patients with Brain Tumors....Pages 269-275
Analysis of Factor VIII RNA from Hemophilia A Patients with no Detectable Mutation in the Coding Regions....Pages 276-278
FISH for Carrier Detection of large Deletions in the Factor VIII Gene....Pages 279-281
Homozygosity Mapping of a Second Gene Locus for Hereditary Combined Deficiency of Vitamin K-Dependent Clotting Factors (FMFD) to Chromosome 16....Pages 282-286
First Case of Compound Heterozygosity in the Gamma-Glutamyl Carboxylase Gene Causing Combined Deficiency of all Vitamin K-Dependent Blood Coagulation Factors....Pages 287-290
Phosphatidylserine in the Neonatal and Adult Platelet Membrane: A Comparison....Pages 291-296
Low Protein C, Tissue Factor Pathway Inhibitor, and Antithrombin allow Sufficient Thrombin Generation in Neonatal Plasma....Pages 297-301
Back Matter....Pages 303-308